512 related articles for article (PubMed ID: 1724447)
21. Modulation of the endotoxin receptor (CD14) in septic patients.
Birkenmaier C; Hong YS; Horn JK
J Trauma; 1992 Apr; 32(4):473-8; discussion 478-9. PubMed ID: 1373777
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
23. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
von Asmuth EJ; Dentener MA; Bazil V; Bouma MG; Leeuwenberg JF; Buurman WA
Immunology; 1993 Sep; 80(1):78-83. PubMed ID: 7503948
[TBL] [Abstract][Full Text] [Related]
24. The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively.
Lin YF; Lee HM; Leu SJ; Tsai YH
J Cell Biochem; 2007 Oct; 102(2):429-41. PubMed ID: 17455194
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
26. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.
Labeta MO; Durieux JJ; Fernandez N; Herrmann R; Ferrara P
Eur J Immunol; 1993 Sep; 23(9):2144-51. PubMed ID: 7690322
[TBL] [Abstract][Full Text] [Related]
27. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester.
Grey ST; Tsuchida A; Hau H; Orthner CL; Salem HH; Hancock WW
J Immunol; 1994 Oct; 153(8):3664-72. PubMed ID: 7523500
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
[TBL] [Abstract][Full Text] [Related]
30. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
31. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
Mizuno K; Okamoto H; Horio T
J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
[TBL] [Abstract][Full Text] [Related]
32. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes.
Arend WP; Ammons JT; Kotzin BL
J Immunol; 1987 Sep; 139(6):1873-9. PubMed ID: 2957441
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta 1 lowers the CD14 content of monocytes.
Hamon G; Mulloy RH; Chen G; Chow R; Birkenmaier C; Horn JK
J Surg Res; 1994 Nov; 57(5):574-8. PubMed ID: 7526045
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
Høgåsen AK; Hestdal K; Abrahamsen TG
J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
38. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
39. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
Wanidworanun C; Strober W
J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
[TBL] [Abstract][Full Text] [Related]
40. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
Corrales I; Weersink AJ; Verhoef J; van Kessel KP
Immunology; 1993 Sep; 80(1):84-9. PubMed ID: 7503949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
